ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase beta-cell mass, promote beta-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research[1].
Molecular Weight:
4366.81
Purity:
98.00
Formula:
C199H294N48O61S
Target:
GCGR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
